Françoise Baleux

USPTO Granted Patents = 12 (Patent Applications = 3)

CIPO Patents = 5

EPO Patents = 10 (Patent Applications = 12)

Average Co-Inventor Count = 4.4

ph-index = 2

Forward Citations = 15(Granted Patents)

Company Filing History:

Centre National De La Recherche Scientifique

patents

4 out of 1,743

Institut National De La Sante Et De La Recherche Medicale

patents

4. 2 out of 4,868

Commissariat À L'Énergie Atomique Et Aux Énergies Alternatives

Université Grenoble Alpes

patents

where one patent can have more than one assignee

Years Active: 2010-2024

Loading Chart...

12 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 11884708 - Stapled peptide inhibitors of nemo as potential anti-inflammatory and anti-cancer drugs (2024-01-30),

2. 11472844 - Peptidomimetics, method of synthesis and uses thereof (2022-10-18),

3. 11149070 - Stapled peptide inhibitors of NEMO as potential anti-inflammatory and anti-cancer drugs (2021-10-19),

4. 10138280 - Polypeptides targeting glycosylated MUC2 proteins, methods of synthesis, their nucleic acids and uses thereof (2018-11-27),

5. 9907860 - Conjugated molecules comprising a peptide derived from the CD4 receptor coupled to an anionic polypeptide for the treatment of AIDS (2018-03-06),

6. 9446109 - [object Object] (2016-09-20),

7. 9382299 - Polypeptides targeting glycosylated MUC2 proteins, methods of synthesis, their nucleic acids and uses thereof (2016-07-05),

8. 9295730 - Conjugated molecules comprising a peptide derived from the CD4 receptor coupled to a polyanion for the treatment of AIDS (2016-03-29),

9. 9078928 - Conjugated molecules comprising a peptide derived from the CD4 receptor coupled to a polyanionic polypeptide for the treatment of AIDS (2015-07-14),

10. 8124380 - [object Object] (2012-02-28),

11. 7820142 - Immunogenic glycopeptides, screening, preparation and uses (2010-10-26),

12. 7700553 - Selective inhibition of NF-κB activation by peptides designed to disrupt nemo oligomerization (2010-04-20),

Title: Françoise Baleux: Innovator in Anti-Inflammatory and Anti-Cancer Drug Development

Introduction

Françoise Baleux is a prominent inventor based in Paris, France. He has made significant contributions to the field of medicine, particularly in the development of innovative drug candidates. With a total of seven patents to his name, Baleux's work focuses on addressing critical health challenges.

Latest Patents

One of his latest patents involves stapled peptide inhibitors of NEMO, which are potential anti-inflammatory and anti-cancer drugs. This invention targets the Nuclear Factor κB (NF-κB) signaling pathway, offering promising avenues for therapeutic interventions. The stapled peptide inhibitors are designed to serve as medicine candidates, particularly in the treatment of inflammatory diseases and cancer.

Career Highlights

Throughout his career, Françoise Baleux has worked with esteemed institutions such as the Institut Pasteur and the Institut National de la Santé et de la Recherche Médicale. His experience in these organizations has allowed him to advance his research and contribute to significant medical advancements.

Collaborations

Baleux has collaborated with notable colleagues, including Laurence Mulard and Armelle Phalipon. These partnerships have enriched his research endeavors and fostered innovation in the field.

Conclusion

Françoise Baleux's work exemplifies the impact of innovative thinking in medicine. His contributions to the development of anti-inflammatory and anti-cancer drugs highlight the importance of research and collaboration in addressing global health issues.

This text is generated by artificial intelligence and may not be accurate.